University of Alabama, Tuscaloo

Open enrollment across a mixed-phase pipeline

According to ClinicalTrials.gov-derived indexes, University of Alabama, Tuscaloo sits in the top decile of US sponsors by registered trial count (#842 of 15,742 sponsors by registered trial count).

17 total trials 13 currently recruiting 3 completed top decile by trial count

University of Alabama, Tuscaloo: 17 sponsored US clinical trials, 13 recruiting.

University of Alabama, Tuscaloo sponsors 17 registered US clinical trials on ClinicalTrials.gov, 13 of them currently recruiting, and 3 completed. The most-studied condition in this pipeline is Other Chronic Illness, with 1 trials.

Top-decile sponsor footprint

University of Alabama, Tuscaloo ranks in the top decile of sponsors by registered trial count (#842 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.

Open and recent trials

17 total, page 1 of 1

RECRUITING NA

Evaluating the Impact of SKY Breath Meditation on Stress, Well-being, and Connection in College Students

NCT07415460
RECRUITING NA

Assessing Pharmacy Technician Educational Training for the Provision of Over-the-Counter Hearing Aids in Rural Alabama and Mississippi Pharmacies

NCT06864273
RECRUITING NA

Strengthening Health and Insight in New Educators

NCT06745934
RECRUITING NA

The Influence of Aerobic Exercise on Consolidation of Fear Extinction Learning in PTSD

NCT06144203
RECRUITING NA

Mindfulness Intervention for College Students With ADHD

NCT06076967
RECRUITING NA

Enhancing Sleep Quality for Nursing Home Residents With Dementia - R33 Phase

NCT05820919
RECRUITING NA

The HOME Study (Healthy Options Made Easy): Telehealth Nutrition Sessions for People Living With Brain Injury

NCT05965947
RECRUITING NA

STEPS Implementation Trial

NCT05695885
RECRUITING NA

Community Stroke Self-management Program

NCT06251128
RECRUITING NA

Spices for Cultivating a Healthy Gut Microbiome and Cardiometabolic Profile

NCT06313580
RECRUITING NA

Minds and Mentors Program- R33

NCT05363371
RECRUITING NA

Facial Affect Sensitivity Training for Young Children With Callous-unemotional Traits

NCT04159168
RECRUITING NA

Improving Access and Affordability of Adult Hearing Healthcare

NCT04671381
ACTIVE NOT RECRUITING NA

Reducing Racism and Discrimination in Schools: Comprehensive Prevention Services

NCT05189769
COMPLETED NA

The Virtual Promotoras Study: eHealth Intervention to Promote Sexual Health Among Young Latina Women in the US South

NCT05632575
COMPLETED

Acute Effects of Watermelon on Vascular Function and Serum Lycopene

NCT03608254
COMPLETED NA

Legacy Intervention Family Enactment (LIFE)

NCT02007564

Therapeutic Areas

Other Chronic Illness 1
Retention Disorders, Cognitive 1
Vascular Health of Postmenopausal Women 1
Medication Assisted Treatment 1
Anxiety Symptoms 1
Brain Injuries 1
Sleep Disorder 1
Affective Symptoms 1
Empathy 1
Health Services Research 1

What is open in the University of Alabama, Tuscaloo pipeline

13 recruiting of 17 indexed (76% open); 3 completed (18%).

Phase labels are sparse on this sponsor index, so phase mix is not charted here.

Top condition: Other Chronic Illness (1 trial), 9 others listed.

How open-pipeline share is computed

Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.

University of Alabama, Tuscaloo: open-pipeline peers nationwide

Peers matched on 17 registered trials and 76% open enrollment, not the therapeutic-area sidebar.

University of Alabama, Tuscaloo sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot). 2×2 strategic matrix plotting 9 entities by Total trials (X) and Recruiting share (Y), with a crosshair dividing the plot into four quadrants. Higher volume & more openFocused & more openHigher volume, mostly closedSmaller & mostly closed 05101520 0%20%40%60%80%100% Total trials Recruiting share University of Alabama, TuscalooAchieve Life SciencesBioDelivery Sciences InternationalChugai PharmaceuticalConvaTecA2 BiotherapeuticsAcepodia BiotechAmerican Laboratory Products CompanyAmryt Pharma
University of Alabama, Tuscaloo sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot).

University of Alabama, Tuscaloo sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.

Sponsors near 17 trials (± recruiting share)

Sponsors near 76% open enrollment (± trial volume)

Related

Read our methodology - how this data is sourced, computed, and verified.

What to do with this University of Alabama, Tuscaloo page

17 registered trials is a research-attention snapshot, not an endorsement of University of Alabama, Tuscaloo or any single study.

  • 13 of University of Alabama, Tuscaloo's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
  • Other Chronic Illness is the condition University of Alabama, Tuscaloo studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Other Chronic Illness trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

University of Alabama, Tuscaloo pipeline card: 17 registered trials from official public datasets.Report a data error.